MyStroke in Chronic Stroke
- Conditions
- Stroke
- Interventions
- Behavioral: MyStroke
- Registration Number
- NCT06057753
- Lead Sponsor
- University of Pennsylvania
- Brief Summary
This is a single-center randomized control trial assessing the impact of a personalized video-based educational platform on patients satisfaction and stroke knowledge in the context of chronic stroke.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ACTIVE_NOT_RECRUITING
- Sex
- All
- Target Recruitment
- 100
- History of ischemic stroke between 1 and 10 years prior to enrollment
- Receiving outpatient stroke care at the Hospital of the University of Pennsylvania
- At least 18 years old
- Access to a smart phone, tablet, or computer
- Willingness to complete 2 follow-up surveys (7 days and 90 day post-enrollment)
- Unwilling or unable to access the customized app with a smartphone, tablet, or computer
- Complete dependence on caregiver for all activities of daily living
- Stroke occurred less than 1 year or greater than 10 years prior to screening/enrollment
- Patient has severe aphasia (score of greater than or equal to 2 on National Institutes of Health Stroke Scale item 9)
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Arm && Interventions
Group Intervention Description MyStroke MyStroke Access to a personalized video-based stroke educational platform
- Primary Outcome Measures
Name Time Method Patient satisfaction with stroke education (90 days) 90 days 5-point Likert-scale (Q: I am satisfied with the quality of my stroke education; Answers range from strongly disagree to strongly agree)
Stroke risk factor recognition (90 days) 90 days The proportion of patients who correctly identify at least one of their vascular risk factors
Stroke etiology recognition (90 days) 90 days The proportion of patients who correctly identify their stroke etiology
- Secondary Outcome Measures
Name Time Method Stroke patient education retention (SPER) survey (90 days) 90 days total score from the 5-question SPER (scale 0-10; higher score reflects better knowledge)
Patient satisfaction with stroke education (7 days) 7 days 5-point Likert-scale (Q: I am satisfied with the quality of my stroke education; Answers range from strongly disagree to strongly agree)
Stroke etiology recognition (7 days) 7 days The proportion of patients who correctly identify their stroke etiology
Stroke patient education retention (SPER) survey (7 days) 7 days total score from the 5-question SPER (scale 0-10; higher score reflects better knowledge)
Stroke prevention medication recognition (7 days) 7 days The proportion of patients who correctly identify their antithrombotic medications
Stroke prevention medication recognition (90 days) 90 days The proportion of patients who correctly identify their antithrombotic medications
EuroQOL - visual analog scale (7 days) 7 days patient-reported quality of life score (scale 0-100; higher score reflects better self-reported quality of life)
Medication adherence (7 days) 7 days total score of the Adherence Estimator (3 question survey; total score 0-36; higher score reflects higher risk of non-adherence)
Stroke risk factor recognition (7 days) 7 days The proportion of patients who correctly identify at least one of their vascular risk factors
EuroQOL - visual analog scale (90 days) 90 days patient-reported quality of life score (scale 0-100; higher score reflects better self-reported quality of life)
modified Rankin Scale 90 days Ordinal functional disability scale (score 0 - 6)
Medication adherence (90 days) 90 days total score of the Adherence Estimator (3 question survey; total score 0-36; higher score reflects higher risk of non-adherence)
Trial Locations
- Locations (1)
The Hospital of the University of Pennsylvania
🇺🇸Philadelphia, Pennsylvania, United States